Abstract
Background
We aimed to determine the optimal thallium 201 chloride (thallium-201) dose using a novel ultrafast cardiac gamma camera with cadmium-zinc-telluride (CZT) solid-state semiconductor detectors (D-SPECT).
Methods and Results
The optimal thallium-201 dose for obtaining left ventricular (LV) myocardial counts was determined from a phantom study. Consecutive 292 patients underwent stress myocardial perfusion imaging with a thallium-201 injection. Stress test comprised exercise or pharmacological (adenosine) provocation. We calculated an optimal thallium-201 dose that resulted in better LV myocardial counts during 6 minutes of acquisition time. We corrected the respective values according to the patient’s age, sex, body mass index (BMI), and type of stress test. The lowest thallium-201 dose for obtaining acceptable imaging was 1.2 million counts. Radiopharmaceutical doses showed a positive correlation with the patient’s age (P < .001), sex (P = .012), BMI (P < .001), and type of stress test (P < .001). Multivariate analysis revealed that the patient’s BMI and the type of stress test were statistically significant factors for determining the correct radiopharmaceutical dose (P < .001 for both).
Conclusions
For clinical use of the CZT SPECT system, the optimal individual thallium-201 doses can be determined based on the patient’s BMI and type of stress test.
Similar content being viewed by others
Abbreviations
- MPI:
-
Myocardial perfusion imaging
- SPECT:
-
Single-photon emission computed tomography
- LV:
-
Left ventricular
- CZT:
-
Cadmium-zinc-telluride
- BMI:
-
Body mass index
- ROI:
-
Region of interest
References
Iskandrian AE, Germano G, VanDecker W, Ogilby JD, Wolf N, Mintz R, et al. Validation of left ventricular volume measurements by gated SPECT 99mTc-labeled sestamibi imaging. J Am Coll Cardiol. 1998;31:331-7.
Hori Y, Yoda S, Nakanishi K, Tano A, Suzuki Y, Matsumoto N, et al. Myocardial ischemic reduction evidenced by gated myocardial perfusion imaging after treatment results in good prognosis in patients with coronary artery disease. J Cardiol. 2015;65:278-84.
Shiraishi S, Sakamoto F, Tsuda N, Yoshida M, Tomiguchi S, Utsunomiya D, et al. Prediction of left main or 3-vessel disease using myocardial perfusion reserve on dynamic thallium-201 single-photon emission computed tomography with a semiconductor gamma camera. Circ J. 2015;79:623-31.
Mannting F, Morgan-Mannting MG. Gated SPECT with technetium-99m-sestamibi for assessment of myocardial perfusion abnormalities. J Nucl Med. 1993;3:601-8.
Jones AG, Abrams MJ, Davison A, Brodack JW, Toothaker AK, Adelstein SJ, et al. Biological studies of a new class of technetium complexes: The hexakis (alkylisonitrile) technetium (I) cations. Int J Nucl Med Biol. 1984;11:225-34.
Narra RK, Hunn AD, Kuczynski BL, Feld T, Wedeking P, Eckelman WC. A neutral technetium-99m complex for myocardial imaging. J Nucl Med. 1989;30:1830-7.
Chen CC, Huang WS, Hung GU, Chen WC, Kao CH, Chen J. Left-ventricular dyssynchrony evaluated by thallium-201 gated SPECT myocardial perfusion imaging: A comparison with Tc-99m sestamibi. Nucl Med Commun. 2013;34:229-32.
Hanif B, Bashir A. Myocardial viability: Assessment and clinical relevance. Pakistan Heart J. 2005;38:57-64.
McLaughlin AF. Thallium scanning. Aust Prescr. 1994;17:57-61.
Thornhill RE, Prato FS, Wisenberg G. The assessment of myocardial viability: A review of current diagnostic imaging approaches. J Cardiovasc Magn Reson. 2002;4:381-410.
Hansen CL, Goldstein RA, Akinboboye OO, Berman DS, Botvinick EH, Churchwell KB, et al. Myocardial perfusion and function: Single photon emission computed tomography. J Nucl Cardiol. 2007;14:39-60.
Naruse H, Daher E, Sinusas A, Jain D, Natale D, Mattera J, et al. Quantitative comparison of planar and SPECT normal data files of thallium-201, technetium-99m-sestamibi, technetium-99m-tetrofosmin and technetium-99m-furifosmin. J Nucl Med. 1996;37:1783-8.
Sharir T, Ben-Haim S, Merzon K, Prochorov V, Dickman D, Ben-Haim S, et al. High-speed myocardial perfusion imaging initial clinical comparison with conventional dual detector anger camera imaging. JACC Cardiovasc Imaging. 2008;1:156-63.
Nakazato R, Slomka PJ, Fish M, Schwartz RG, Hayes SW, Thomson LE, et al. Quantitative high-efficiency cadmium-zinc-telluride SPECT with dedicated parallel-hole collimation system in obese patients: Results of a multi-center study. J Nucl Cardiol. 2015;22:266-75.
Songy B, Lussato D, Guernou M, Queneau M, Geronazzo R. Comparison of myocardial perfusion imaging using thallium-201 between a new cadmium-zinc-telluride cardiac camera and a conventional SPECT camera. Clin Nucl Med. 2011;36:776-80.
Slomka PJ, Patton JA, Berman DS, Germano G. Advances in technical aspects of myocardial perfusion SPECT imaging. J Nucl Cardiol. 2009;16:255-76.
Erlandsson K, Kacperski K, van Gramberg D, Hutton BF. Performance evaluation of D-SPECT: A novel SPECT system for nuclear cardiology. Phys Med Biol. 2009;54:2635-49.
Baggish AL, Boucher CA. Radiopharmaceutical agents for myocardial perfusion imaging. Circulation. 2008;118:1668-74.
Cerqueira MD, Allman KC, Ficaro EP, Hansen CL, Nichols KJ, Thompson RC, et al. Recommendations for reducing radiation exposure in myocardial perfusion imaging. J Nucl Cardiol. 2010;17:709-18.
Dorbala S, Di Carli MF, Delbeke D, Abbara S, DePuey EG, Dilsizian V, et al. SNMMI/ASNC/SCCT guideline for cardiac SPECT/CT and PET/CT 1.0. J Nucl Med. 2013;54:1485-507.
Verberne HJ, Acampa W, Anagnostopoulos C, Ballinger J, Bengel F, De Bondt P, et al. EANM procedural guidelines for radionuclide myocardial perfusion imaging with SPECT and SPECT/CT: 2015 revision. Eur J Nucl Med Mol Imaging. 2015;42:1929-40.
Nakazato R, Berman DS, Hayes SW, Fish M, Padgett R, Xu Y, et al. Myocardial perfusion imaging with a solid-state camera: Simulation of a very low dose imaging protocol. J Nucl Med. 2013;54:373-9.
Iskandrian AS, Verani MS, Heo J. Pharmacologic stress testing: Mechanism of action, hemodynamic responses, and results in detection of coronary artery disease. J Nucl Cardiol. 1994;1:94-111.
Lee J, Chae SC, Lee K, Heo J, Iskandrian AS. Biokinetics of thallium-201 in normal subjects: Comparison between adenosine, dipyridamole, dobutamine and exercise. J Nucl Med. 1994;35:535-41.
Duvernoy CS, Meyer C, Seifert-Klauss V, Dayanikli F, Matsunari I, Rattenhuber J, et al. Gender differences in myocardial blood flow dynamics: Lipid profile and hemodynamic effects. J Am Coll Cardiol. 1999;33:463-70.
Chareonthaitawee P, Kaufmann PA, Rimoldi O, Camici PG. Heterogeneity of resting and hyperemic myocardial blood flow in healthy humans. Cardiovasc Res. 2001;50:151-61.
Acknowledgements
The authors thank all of their coworkers—radiological technologists and cardiologists—of Hyogo Brain and Heart Center at Himeji.
Disclosures
MS Masaru Ishihara, Dr. Yasuyo Taniguchi, Professor Masahisa Onoguchi, and MS Takayuki Shibutani have nothing to disclose.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ishihara, M., Taniguchi, Y., Onoguchi, M. et al. Optimal thallium-201 dose in cadmium-zinc-telluride SPECT myocardial perfusion imaging. J. Nucl. Cardiol. 25, 947–954 (2018). https://doi.org/10.1007/s12350-016-0749-z
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12350-016-0749-z